Delivery Order SPE2DB22D3016-SPE2DB24FBGG2
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $17,514.60 firm fixed-price delivery order is for the supply of 4565536929 CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of August 22, 2024 and is not set aside for any specific business type. Amerisourcebergen holds several Indefinite Delivery...
This federal contract award, valued at $4,445.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565913704 CONTRAVE ER 8-90 MG TABLET 120S. The contract is a Firm Fixed Price delivery order with a completion date of September 24, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) to supply a wide range of...
This federal contract award, valued at $1,199.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 14, 2024. Amerisourcebergen, through its Corporate Office division, will supply these pharmaceutical products to support military treatment facilities and programs. This award is not...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,770.41 firm-fixed-price delivery order is for the supply of 4565404232 ! CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of August 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of its extensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,119.46 firm fixed-price delivery order is for CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,578.41 Firm Fixed Price Delivery Order contract is for the supply of 4566177401 CONTRAVE ER 8-90 MG TABLET 120S, a specialty medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $13,173.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of November 24, 2023 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,216.00 Delivery Order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $15,182.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, and has an ultimate completion date of January 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...